Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MARAT Study: Pharmacokinetics of maraviroc and boosted atazanavir dual regimen in stable HIV-infected patients
2014-004692-22Phase 3Active
- Sponsor
- University of Turin
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of maraviroc, atazanavir and ritonavir in human immunodeficiency virus infection (HIV), sponsored by University of Turin. Primary endpoint: Maraviroc and atazanavir trough concentrations. Started Jan 2015; status: active.
02
Drugs
maravirocatazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-004692-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004692-22.